Search

everythinglearnresearchcommunity

for

Search:↓

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Women with high androgen levels may have more severe COVID-19 symptoms.

Finasteride may help some women with hair loss, but better options exist.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Women with irregular periods have a higher risk of heart disease.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Finasteride improves hair density and thickness in women with hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.